Chemomab Therapeutics annual shares outstanding
2018
2019
2020
Chemomab Therapeutics Shares Outstanding History (CMMB)
Chemomab Therapeutics reported 148.4M shares outstanding at the end of fiscal 2020.
View full Chemomab Therapeutics company overviewChemomab Therapeutics annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2020 | 2020-12-31 | 148.4M | 0 | 0.00% |
| 2019 | 2019-12-31 | 148.4M | 86.1M | +138.19% |
| 2018 | 2018-12-31 | 62.3M | — | — |
Chemomab Therapeutics quarterly shares outstanding
Q4.18
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q2.24
Q2.25
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2025 | 2025-06-30 | 413.9M | 181.2M | +77.90% |
| Q2 2024 | 2024-06-30 | 287.2M | 58.2M | +25.40% |
| Q2 2023 | 2023-06-30 | 248.1M | 19.4M | +8.50% |
| Q1 2023 | 2023-03-31 | 232.6M | 4.5M | +1.99% |
| Q4 2022 | 2022-12-31 | 232.6M | 4.5M | +1.99% |
| Q3 2022 | 2022-09-30 | 229.0M | 1.1M | +0.46% |
| Q2 2022 | 2022-06-30 | 228.6M | 677,060 | +0.30% |
| Q1 2022 | 2022-03-31 | 228.1M | 14.1M | +6.60% |
| Q4 2021 | 2021-12-31 | 228.1M | 218.8M | +2359.24% |
| Q3 2021 | 2021-09-30 | 228.0M | 79.6M | +53.61% |
| Q2 2021 | 2021-06-30 | 228.0M | 79.6M | +53.61% |
| Q1 2021 | 2021-03-31 | 214.0M | 65.6M | +44.18% |
| Q4 2020 | 2020-12-31 | 9.3M | −139.1M | −93.75% |
| Q3 2020 | 2020-09-30 | 148.4M | 86.1M | +138.19% |
| Q2 2020 | 2020-06-30 | 148.4M | — | — |
| Q1 2020 | 2020-03-31 | 148.4M | — | — |
| Q4 2019 | 2019-12-31 | 148.4M | — | — |
| Q4 2018 | 2018-12-31 | 62.3M | — | — |
Chemomab Therapeutics shares outstanding trends
Across the available reported history, Chemomab Therapeutics's shares outstanding moved from 148.4M to 148.4M, a change of 0. The latest reported quarter, Q2 2025, shows 413.9M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Chemomab Therapeutics filings at SEC.gov ↗